RxDoctor Payments Data

Dale Haverstick, MD

Family Medicine · Eminence, MONPI 1902983075

Payments from drug & device makers

$494in general payments, 2019–2025

Across 30 payments — averaging $16.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$63
  • Novo Nordisk$57
  • Lilly USA, LLC$52
  • Amgen$44
  • AbbVie$41
  • Abbott$40
  • plus $195 from 11 others

What the payments were for

  • Food & beverage$494100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$494 in reported general payments places this provider in the 50th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$78,273
Medicare patients
211
Services billed
2,061

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide101$116,251
JardianceEmpagliflozin102$77,804
EliquisApixaban89$74,359
OzempicSemaglutide52$59,897
XareltoRivaroxaban84$56,157
FarxigaDapagliflozin Propanediol67$53,621
OxycontinOxycodone Hcl31$42,351
LinzessLinaclotide57$34,813
TrulicityDulaglutide31$33,351
Trelegy ElliptaFluticasone/Umeclidin/Vilanter40$28,314
Tresiba Flextouch U-100Insulin Degludec12$28,067
Tresiba Flextouch U-200Insulin Degludec16$25,309
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog30$21,816
RexultiBrexpiprazole11$16,890
MyrbetriqMirabegron19$14,020

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$52$149,602132 claims
Boehringer IngelheimJardiance, Tradjenta, Stiolto Respimat$63$101,409132 claims
Novo NordiskOzempic$57$59,89752 claims
Johnson & JohnsonXarelto$13$56,15784 claims
AstraZenecaFarxiga$16$53,62167 claims
AbbVieLinzess$41$34,81357 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Eminence

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →